PRCT files Form 144 for restricted stock vesting

PRCT submitted a Form 144 notice reporting a proposed sale of Common stock tied to a restricted stock vesting event dated 03/16/2026.

Accepted by SEC EDGAR 03/17/2026 - 03:13 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

PRCT submitted a Form 144 notice reporting a proposed sale of Common stock tied to a restricted stock vesting event dated 03/16/2026. The filing also records a prior sale by Kevin Waters of 6,721 shares on 03/06/2026 for $159,300.47.

Insights

Securities Compliance Counsel

Form 144 notifies the market of an intended sale tied to vesting; prior sale details are disclosed.

The notice lists a proposed sale of Common stock associated with a restricted stock vesting on 03/16/2026. Filings of this type serve as a regulatory notice under resale rules for insiders and affiliates.

Cash‑flow treatment and the exact number of shares proposed for resale are not specified in the excerpt; the filing does list a prior sale by Kevin Waters of 6,721 shares on 03/06/2026 for $159,300.47. Subsequent disclosures or broker statements would show actual sale timing and executed amounts.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does PRCT's Form 144 filing mean?

It is a regulatory notice of a proposed sale of PRCT common stock tied to restricted stock vesting on 03/16/2026. Such filings inform the market when insiders or affiliates intend to resell securities under resale rules; execution details are reported separately when sales occur.

Who is the individual associated with recent sales in the PRCT filing?

The filing identifies Kevin Waters as having sold 6,721 shares on 03/06/2026 for $159,300.47. This prior sale is disclosed in the Form 144's "Securities Sold During The Past 3 Months" section.

Is the proposed sale tied to compensation or vesting for PRCT?

Yes; the excerpt states the securities to be sold relate to Restricted Stock Vesting with an event date of 03/16/2026. The filing links the proposed resale to issuer compensation vesting rather than an open‑market purchase.

Does the Form 144 specify how many shares are proposed for sale?

The provided excerpt does not state a clear proposed sale quantity for the vesting event. It does, however, list a prior executed sale of 6,721 shares on 03/06/2026 for $159,300.47.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001653771
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	PROCEPT BioRobotics Corp
SEC File Number	001-40797
Address of Issuer	150 BAYTECH DRIVE SAN JOSE CALIFORNIA 95134
Phone	6502329832
Name of Person for Whose Account the Securities are To Be Sold	Waters Kevin
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	706	19876.16	56390196	03/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/16/2026	Restricted Stock Vesting	Issuer			706	03/16/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Kevin Waters 150 Baytech Drive San Jose CA 95134	Common	03/06/2026	6721	159300.47

144: Remarks and Signature

Remarks	Sale includes an amount necessary to cover a tax obligation resulting from the settlement of a vested equity award distribution.
Date of Notice	03/17/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Gerardo Ibarra-Munoz, as a duly authorized representative of Fidelity Brokerage Services LLC, as attorney-in-fact for Kevin Waters
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)